News

Target (TGT) is under fresh scrutiny after being named in a lawsuit tied to Nara Organics infant formula that allegedly caused a confirmed case of infant botulism in Washington, which is part of a broader FDA and CDC outbreak investigation. See our latest analysis for Target. The Nara Organics lawsuit lands at a time when Target's share price has a year to date return of 39.63% and a 1 year total shareholder return of 37.63%, while its 5 year total shareholder return is down 36.52%. This...

Target has initiated a voluntary nationwide recall of certain Up & Up baby wipes after FDA testing detected harmful bacteria in specific batches. The recall follows reports of serious infections potentially linked to the affected products, raising health concerns for infants and young children. This development creates additional reputational and regulatory scrutiny for Target as it manages product quality and safety across its private label portfolio. For investors watching NYSE:TGT, this...

Target has issued a voluntary nationwide recall of select Up & Up baby wipes after FDA testing found contamination with Burkholderia cepacia complex and Burkholderia gladioli bacteria. The recall affects multiple lots of a popular store brand product used primarily by infants and young children. Target is advising customers to stop using the affected wipes and return them to stores for a refund. For investors watching NYSE:TGT, this recall lands at a time when the stock is trading around...